Looking at systemic treatment before breast cancer surgery Newsletter Article 06 February 2013 Pages: 2 - 2
Examining the benefits of dietary phytoestrogens Peter Harrigan Newsletter Article 06 February 2013 Pages: 3 - 4
Individual choice limited by long-acting contraceptives? Newsletter Article 06 February 2013 Pages: 5 - 5
Medication and follow-up reduce idiopathic anaphylaxis costs Newsletter Article 06 February 2013 Pages: 6 - 6
Battle of docetaxel and paclitaxel in metastatic breast cancer Newsletter Article 06 February 2013 Pages: 7 - 7
Chimeric Lym-1/interleukin-2 fusion protein in lymphoma Newsletter Article 06 February 2013 Pages: 9 - 9
Raltitrexed: cost-effective therapy for colorectal cancer Larry Prescott Newsletter Article 06 February 2013 Pages: 11 - 12
Zidovudine recommended for all pregnant women with HIV Newsletter Article 06 February 2013 Pages: 13 - 13
Fluconazole vs amphotericin B for invasive candidiasis Newsletter Article 06 February 2013 Pages: 13 - 13
‘Moderate’ anticoagulation effective after valve replacement Newsletter Article 06 February 2013 Pages: 15 - 15
Multivitamin use reduces risk of conotruncal defects Newsletter Article 06 February 2013 Pages: 16 - 16
Low-dose follitropin-alfa effective for ovulation induction Newsletter Article 06 February 2013 Pages: 16 - 16
HRT reduces late restenosis in post-menopausal women Newsletter Article 06 February 2013 Pages: 17 - 17
Magnesium sulfate effective in pre-eclampsia and eclampsia Newsletter Article 06 February 2013 Pages: 17 - 17
Famotidine and ranitidine provide prolonged acid suppression Newsletter Article 06 February 2013 Pages: 18 - 18
Important lessons from disappointing trial of vesnarinone in CHF Gill Higgins Newsletter Article 06 February 2013 Pages: 19 - 20
Acellular DTP vaccine causes less drowsiness than whole-cell vaccine Newsletter Article 06 February 2013 Pages: 21 - 21
Misoprostol, H2-antagonists for preventing GI damage with NSAIDs Newsletter Article 06 February 2013 Pages: 21 - 21
Donepezil: easing the burden in Alzheimer’s disease Newsletter Article 06 February 2013 Pages: 22 - 22
Omeprazole approved for first-line treatment of GORD Newsletter Article 06 February 2013 Pages: 22 - 22